CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Auricchio, F.
Right arrow Articles by Bilancio, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Auricchio, F.
Right arrow Articles by Bilancio, A.

Cell Growth & Differentiation, Vol 6, Issue 2 105-113, Copyright © 1995 by American Association of Cancer Research


ARTICLES

The role of estradiol receptor in the proliferative activity of vanadate on MCF-7 cells

F Auricchio, M Di Domenico, A Migliaccio, G Castoria and A Bilancio
II Cattedra di Patologia Generale, Facolta di Medicina e Chirurgia, II Universita di Napoli, Italy.

Vanadate stimulates growth of the estradiol-responsive MCF-7 cells in the absence of estrogens through a mechanism requiring tyrosine kinase activity. The proliferative effect of vanadate is mediated by estradiol receptor, and is inhibited by three antiestrogens, hydroxytamoxifen, ICI 164,384, and ICI 182,780. Estradiol abolishes the inhibitory effect of ICI 164,384 or ICI 182,780. Before stimulating cell proliferation, vanadate induces accumulation of tyrosine phosphorylation in several proteins including estradiol receptor and epidermal growth factor receptor. In addition, vanadate increases the binding activity of the estradiol receptor for its ligand. This is the first evidence of in vivo association between estradiol receptor tyrosine phosphorylation and its hormone-binding activation. Antiestrogens abolish the vanadate effect on estradiol receptor and epidermal growth factor receptor phosphorylation and reduce it on general protein tyrosine phosphorylation. These findings show that vanadate, apparently through estradiol receptor tyrosine phosphorylation, triggers activity of this receptor, which in turn stimulates protein tyrosine phosphorylation and induces cell proliferation.


This article has been cited by other articles:


Home page
JCOHome page
X. Cui, R. Schiff, G. Arpino, C. K. Osborne, and A. V. Lee
Biology of Progesterone Receptor Loss in Breast Cancer and Its Implications for Endocrine Therapy
J. Clin. Oncol., October 20, 2005; 23(30): 7721 - 7735.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. K. Osborne, J. Shou, S. Massarweh, and R. Schiff
Crosstalk between Estrogen Receptor and Growth Factor Receptor Pathways as a Cause for Endocrine Therapy Resistance in Breast Cancer
Clin. Cancer Res., January 15, 2005; 11(2): 865s - 870s.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
V. G. Keshamouni, R. R. Mattingly, and K. B. Reddy
Mechanism of 17-{beta}-Estradiol-induced Erk1/2 Activation in Breast Cancer Cells: A ROLE FOR HER2 AND PKC-{delta}
J. Biol. Chem., June 21, 2002; 277(25): 22558 - 22565.
[Abstract] [Full Text] [PDF]


Home page
EMBO J.Home page
A. Migliaccio, G. Castoria, M. D. Domenico, A. de Falco, A. Bilancio, M. Lombardi, M. V. Barone, D. Ametrano, M. S. Zannini, C. Abbondanza, et al.
Steroid-induced androgen receptor-oestradiol receptor {beta}-Src complex triggers prostate cancer cell proliferation
EMBO J., October 16, 2000; 19(20): 5406 - 5417.
[Abstract] [Full Text] [PDF]


Home page
EMBO J.Home page
G. Castoria, M. V. Barone, M. Di Domenico, A. Bilancio, D. Ametrano, A. Migliaccio, and F. Auricchio
Non-transcriptional action of oestradiol and progestin triggers DNA synthesis
EMBO J., May 4, 1999; 18(9): 2500 - 2510.
[Abstract] [Full Text] [PDF]


Home page
EMBO J.Home page
A. Migliaccio, D. Piccolo, G. Castoria, M. Di Domenico, A. Bilancio, M. Lombardi, W. Gong, M. Beato, and F. Auricchio
Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor
EMBO J., April 1, 1998; 17(7): 2008 - 2018.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1995 by the American Association of Cancer Research.